Breast Cancer Diagnostic and Treatment Devices

This analysis includes a discussion of competitors, markets (current and future), products, and opportunities in the global market for breast cancer diagnostic and treatment devices.

The report provides the following useful information:

• an epidemiological overview of breast cancer and its subtypes
• product analysis by imaging, biopsy, and treatment segment
• competitive analysis of industry leaders and emerging competitors
• insight into factors driving and limiting market growth estimated market forecasts

Report Highlights:

• Total unit sales of diagnostic and treatment devices for breast cancer are increasing due to the increasing burden of breast cancer, accessibility to breast imaging and diagnostic technologies, and availability of new breast-conserving treatment options.
• Diagnostic devices accounted for the majority of total sales of breast cancer diagnostic and treatment devices. Diagnostic devices for breast cancer accounted for approximately 98% of total product sales in 2017.
• The global market for breast cancer diagnostic and treatment devices is anticipated to increase at a CAGR of 6.2% during the forecast period (2017-22), reaching approximately $5.96bn in total product sales by 2022.
• The US was the largest market for diagnostic and treatment breast cancer device sales. Strong device sales in the US market are a result of favourable socioeconomic factors and a high participation rate by women in screening programs.
• The competitive landscape is diverse due to the range of devices available for breast cancer diagnosis and treatment. Across diagnostic and therapeutic device markets covered, Hologic is the leading vendor based on Meddevicetracker estimates.

Topics Covered Include:

• An overview of diagnostic and therapeutic devices used in the management of breast cancer patients.
• Diagnostic products covered by this report include mammography and other imaging systems, CAD software for diagnostic breast cancer imaging, and biopsy devices.
• Breast cancer treatment devices covered by this report include lumpectomy guidance systems, breast irradiation systems, and minimally invasive ablation devices.
• Global and country/region-specific market forecasts, including forecasts by product segment.
• Competitive analyses.
• Discussion of key drivers and limiters impacting the market for diagnostic and treatment devices for breast cancer.
• A review of emerging technologies which could impact sales of existing devices.